Target intelligence / Profile preview

Pleckstrin homology domain-containing family G member 2 (PLEKHG2)

Target
PLEKHG2
Molecular classification
Guanine nucleotide exchange factor (GEF), RhoGEF, Signaling protein, large multidomain protein with Dbl homology (DH) and pleckstrin homology (PH) domains
01

Overview

PLEKHG2 is a large multidomain signaling protein (about 1300 amino acids, 130 kDa) that functions as a guanine nucleotide exchange factor (GEF) mainly for the Rho family GTPases Rac1 and Cdc42, with recognized roles in regulating actin polymerization and cell morphology. It is activated by direct interaction with the beta and gamma subunits of heterotrimeric G proteins downstream of G protein-coupled receptors, enabling key cellular processes such as chemotaxis and cell motility. PLEKHG2 is implicated in the development and maintenance of neuronal structures, including axons, dendrites, and synaptic spines, with mutations (esp. Arg204Trp) causing severe neurodevelopmental disorders such as microcephaly, intellectual disability, and dystonia. It also has oncogenic potential, particularly in leukemias. Protein interactions include Gβγ, β-actin, FHL1, and Gαs, and it is subject to regulation by phosphorylation via signals such as SRC and EGFR. The precise physiological role and therapeutic targeting strategies remain under investigation.

Other names
ARHGEF42CLGLDAMDFLJ00018CTB-60E11.4common-site lymphoma/leukemia guanine nucleotide exchange factorPH domain-containing family G member 2pleckstrin homology and RhoGEF domain containing G2
02

Biological functions

Regulation of actin cytoskeleton polymerizationActivation of Rho family small GTPases (Rac1, Cdc42)Signal transduction downstream of G protein-coupled receptors (via Gβγ interaction)Cell morphology regulationCell motility and chemotaxis (particularly in lymphocytes)Neuronal network development (axons, dendrites, and synaptic spines)
03

Disease associations

Cancer (especially leukemia, as a transforming oncogene, acute myeloid leukemia association)Neurodevelopmental disorders (postnatal microcephaly, intellectual disability, dystonia)Leukodystrophy
04

Safety considerations

Disruption or mutation (e.g., Arg204Trp) leads to defective neuronal development, microcephaly, intellectual disability, altered axon/dendrite/spine morphology, and leukodystrophyPotential oncogenic transformation when over-activated or mutated
05

Biomarkers

Mutational status, especially Arg204Trp variant, in neurodevelopmental disorders

Beyond the preview

Go deeper on Pleckstrin homology domain-containing family G member 2 (PLEKHG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pleckstrin homology domain-containing family G member 2 (PLEKHG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call